Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

Belarus

Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk

Russia

B. Braun Avitum Russland Clinics Ltd., Saint Petersburg